SmartTRAK's Anne Staylor, VP & GM Neuro Therapies, will be attending ESMINT 2024
SmartTRAK is excited to attend the ESMINT Congress 2024, which will be held at the Pharo Congress Center in Marseille, France, September 4-6. Anne Staylor, SmartTRAK VP & GM Neuro Therapies, will be there to cover the latest Neurovascular news and developments. In this Market Snapshot video update, Anne provides the latest research and technologies impacting the market for neuro intervention, including trends to look for at the meeting.
If you'd like to meet with Anne at ESMINT, or see more of SmartTRAK's neuro coverage, just click the button below to visit SmartTRAK Neurovascular Central.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
